The removal of damaged material from within atherosclerotic plaques (“fatty streaks”) to restore cardiovascular health is a key component of SENS, now being developed for the clinic by SRF ally Underdog Pharmaceuticals. Exciting new preclinical results from another group using this strategy have recently been published in ACS Nano.
Defatting the Streaks
- By SRF
- August 12, 2020
- 10:08 am
The removal of damaged material from within atherosclerotic plaques ("fatty streaks") to restore cardiovascular health is a key component of SENS, now being developed for the clinic by SRF ally Underdog Pharmaceuticals. Exciting new preclinical results from another group using this strategy have recently been published in ACS Nano.

- By SRF
- August 12, 2020
- 10:08 am
Recent Posts:
Announcing the Biomarkers of Aging Consortium
SRF March 10, 2023 12:56 pm
Action at the Governmental Level for Longevity
SRF March 10, 2023 12:30 pm
Scenes from the Lab
SRF March 8, 2023 5:16 pm
A Busy Spring in the Education Department
SRF March 8, 2023 4:22 pm
New Peer-Reviewed Paper from SENS Research Foundation: Iron Homeostasis as a Senolytic Target
SRF February 8, 2023 5:47 pm
Announcement: Amicable Settlement of Donor Dispute
SRF October 28, 2022 3:34 pm
The Zombie Problem Happening Inside You
Maria Entraigues Abramson September 9, 2022 7:50 pm
Announcing the new Chairman of the SRF Board of Directors
SRF May 9, 2022 5:57 pm
A Message from the SRF Board of Directors
SRF April 15, 2022 8:11 pm
New Peer-Reviewed Paper from SENS Research Foundation Reports a Better Method to Study How Immune Cells Seek and Destroy Senescent Cells
Michael Rae April 12, 2022 2:02 am
We are thrilled to announce the expansion of our Research Center
SRF April 1, 2022 11:25 pm